MacDee
NDC 55714-4827, Aconitum napellus, Aurum metallicum, Baryta carbonica, Belladonna, Crotalus horridus, Euphrasia officinalis, Gelsemium sempervirens, Hamamelis virginiana, Lachesis mutus, Mercurius vivus, Phosphorus, Picricum acidum, Plumbum metallicum, Pulsatilla, Rhus toxicodendron, Stramonium, Theridion, Elaps corallinus., liquid, from Newton Laboratories, Inc..
- Product NDC
- 55714-4827
- Status
- Listed
- Labeler
- Newton Laboratories, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55714-4827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACONITUM NAPELLUS15 [hp_X]/mL
- BARIUM CARBONATE15 [hp_X]/mL
- ATROPA BELLADONNA15 [hp_X]/mL
- CROTALUS HORRIDUS HORRIDUS VENOM15 [hp_X]/mL
- EUPHRASIA STRICTA15 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT15 [hp_X]/mL
- HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK15 [hp_X]/mL
- LACHESIS MUTA VENOM15 [hp_X]/mL
- MERCURY15 [hp_X]/mL
- PHOSPHORUS15 [hp_X]/mL
- PICRIC ACID15 [hp_X]/mL
- LEAD15 [hp_X]/mL
- ANEMONE PULSATILLA15 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF15 [hp_X]/mL
- DATURA STRAMONIUM15 [hp_X]/mL
- THERIDION CURASSAVICUM15 [hp_X]/mL
- MICRURUS CORALLINUS VENOM30 [hp_X]/mL
- GOLD15 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55714-4827-1 | 55714482701 | 30 mL in 1 BOTTLE, GLASS (55714-4827-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55714-4827 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55714-4827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55714-4827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.